For
the past 25 years, he has worked on advancing the promise of personalized
medicine in both therapeutics and diagnostics industries, in roles ranging from
bench research to business development. His most recent corporate role was as
SVP of Clinical Product Strategy at Thrive Earlier Detection (sold $2.2B to
Exact Sciences).
He
currently advises executive teams at a number of diagnostics and biotechnology
startups, focused primarily on questions of product design, clinical and
regulatory strategy, and organizational development.
Dr.
Parker is a population geneticist and evolutionary biologist by training and
received a BS in Philosophy Biology from the University of New Mexico and a PhD
in Molecular Genetics from the University of Maine.
